Jobs / United States / Glaxosmithkline LLC
Site Engagement Associate Director - Oncology
Glaxosmithkline LLC · 🇺🇸 USA - Pennsylvania - Philadelphia
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Glaxosmithkline LLC paid sponsored hires in similar roles1 certified filing for “Associate Director - Global Regulatory Affairs, Oncology” (Regulatory Affairs Managers) in WA: $154k–$154k, median $154k. Most were filed at wage level II (100%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Glaxosmithkline LLC
The US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Glaxosmithkline LLC →
About the role
At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our understanding of the immune system with cutting-edge technology to transform people’s lives. GSK fosters a culture ambitious for patients, accountable for impact, and committed to doing the right thing, making sure that we focus our efforts on accelerating significant assets that meet patients’ needs and have the highest probability of success. We’re uniting science, technology, and talent to get ahead of disease together. Find out more: Our approach to R&D Through leadership, the Site Engagement Associate Director is accountable for developing, managing, and overseeing long-term and strong relationships with strategically and operationally important sites and institutions. It includes building and enhancing the image and reputation of GSK with sites locally and providing an interface between GSK and the sites to create an optimal clinical trials environment to generate results in a timely manner with high-quality outputs. Responsibilities This role will provide YOU the opportunity to lead key activities to progress YOUR career. These responsibilities include some of the following: · Conduct strategic environmental surveillance of the United States to anticipate regulatory and operational changes affecting sites and R&D and use those insights to design innovative, efficient partnerships. · Provide insight to leadership on site landscape trends, operational risks, and emerging engagement models. · Lead the development and expansion of a US site network spanning academic centers, community practices, and emerging site model (hybrid networks, DCT enabled sites. · Enhance collaboration between sites and GSK clinical teams to improve performance and resolve obstacles during site start‑up and study execution. · Create and implement strategic partnership models and frameworks for strategic clinical sites. · Build and nurture relationships with community sites, engaging local investigators and staff to expand the GSK partnership network · Give an operational vision of the future GSK portfolio (collaborating with local MA) to key external stakeholders in order to anticipate partnerships and to help them to better prepare the arrival of clinical trials · Provide strategic input for operational excellence, process efficiency and trial delivery both internally and externally · Identify and disseminate best practices and contribute to standardization across local operations · Track compliance with site partnership agreements, pinpoint problem areas, and take corrective actions to ensure successful outcomes. · Collaborate, communicate, and resolve key operational issues with external site partners · Drive performance, by putting in place mutually agreed KPIs (quality and performance) and organizing periodic review with the different external partners · Provide feedback to Leadership, Local Medical Affairs, LOC regarding the development of new partnerships and updates on existing ones · Responsible for standardizing processes, identifying and sharing best practices at internal cross functional process improvement teams · Champion patient centric solutions and representative strategies tailored to U.S. oncology populations · Collaborate with Feasibility, Clinical Operations, and Medical Affairs to drive optimal site placement and study performance · Partner with cross functional teams to optimize site activation timelines (regulatory packets, budgets/CTAs, onboarding, training). · Identify bottlenecks at both the study and s